@article {10.3844/ajidsp.2015.113.116,
article_type = {journal},
title = {Disseminated Fusarium Infections in Patients Receiving Posaconazole Prophylaxis: A Report of 2 Patients and Brief Review of the Literature},
author = {Fournier, John Byrne and Thomas, Vinod and Breen, Catherine and Cannella, Jonathan and Heiner, Douglas and Roberts, Todd and Skowron, Gail},
volume = {11},
number = {4},
year = {2015},
month = {Nov},
pages = {113-116},
doi = {10.3844/ajidsp.2015.113.116},
url = {https://thescipub.com/abstract/ajidsp.2015.113.116},
abstract = {Fusarium is a filamentous fungi that has emerged as a frequent cause of invasive infections in immunocompromised patients. Dermatologists often play a critical role in diagnosing fusariosis, as greater than 70% of patients with disseminated infections have cutaneous involvement, and microbiologic evaluation of skin specimens provides the diagnosis in the majority of cases. Second-generation triazoles are typically the most effective medications in treating invasive Fusarium infections, and we discuss the benefits of using these medications, as well as detail the side effects of these therapeutic agents.},
journal = {American Journal of Infectious Diseases},
publisher = {Science Publications}
}